SCHEMBL974064

SCHEMBL974064

O=C(O)[C@H](O)c1ccccc1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.54
MAPK1 P28482 1/20 0.54
GABRA1 P14867 1/20 0.48
GABRB2 P47870 1/20 0.48
TSHR P16473 1/20 0.43
HPGD P15428 3/20 0.43
CA12 O43570 3/20 0.43
CA2 P00918 3/20 0.43
CA14 Q9ULX7 3/20 0.43
CA1 P00915 2/20 0.43
CA7 P43166 2/20 0.43
CA9 Q16790 2/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
CA4 P22748 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
HMGB1 P09429 1/20 0.43
CA6 P23280 1/20 0.43
NAPRT Q6XQN6 1/20 0.43
POLB P06746 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL974062 1.00 LMNA (0.54) LMNAMAPK1GABRA1GABRB2TSHR
SCHEMBL11349953 1.00 LMNA (0.54) LMNAMAPK1GABRA1GABRB2TSHR
SCHEMBL31107080 1.00 LMNA (0.54) LMNAMAPK1GABRA1GABRB2TSHR
SCHEMBL7522933 0.98 LMNA (0.52) LMNAMAPK1GABRA1GABRB2TSHR
Hydrochloric Acid SCHEMBL1375900 0.98 LMNA (0.52) LMNAMAPK1GABRA1GABRB2TSHR
SCHEMBL7522050 0.98 LMNA (0.52) LMNAMAPK1GABRA1GABRB2TSHR
Ammonia Solution, Strong SCHEMBL7523599 0.98 LMNA (0.52) LMNAMAPK1GABRA1GABRB2TSHR
SCHEMBL7522924 0.98 LMNA (0.52) LMNAMAPK1GABRA1GABRB2TSHR
Water SCHEMBL7529368 0.98 LMNA (0.52) LMNAMAPK1GABRA1GABRB2TSHR
SCHEMBL7522058 0.98 LMNA (0.52) LMNAMAPK1GABRA1GABRB2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109467502-B Method for splitting mandelic acid compound enantiomer 湖南科技大学 2021-07-30 CN claimed
CN-109467502-A A method of splitting almond acid compounds enantiomer 湖南科技大学 2019-03-15 CN claimed
US-6359172-B1 Method of preparing 2- and 4-hydroxymandelic acid GERARD KESSELS SOCIEDAD ANONIMA, S.A. (ES) 2002-03-19 US claimed
EP-0987245-B1 A method of preparing 2- and 4-hydroxymandelic acid GERARD KESSELS S A (ES) 2002-03-13 EP claimed
EP-0987245-A1 A method of preparing 2- and 4-hydroxymandelic acid Gerard Kessels S.A. (ES) 2000-03-22 EP claimed
EP-0536960-B1 Preparation of 2-hydroxymandelic acids and 2-hydroxybenzaldehydes ZENECA LTD (GB) 1996-09-11 EP claimed
US-5248816-A From glycolic acid and borate IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-09-28 US claimed
EP-0536960-A2 Preparation of 2-hydroxymandelic acids and 2-hydroxybenzaldehydes ZENECA LIMITED (GB) 1993-04-14 EP claimed
JP-5201917-A None JP disclosed
WO-2025243298-A1 NOVEL SUBSTITUTED AMINOCYCLOHEXANECARBONITRILES ADAMA MAKHTESHIM LTD. (IL) 2025-11-27 WO disclosed
US-20230416182-A1 PROCESS FOR PREPARING FRAMBIONE RHODIA OPERATIONS (FR) 2023-12-28 US disclosed
CN-108047033-B Reaction device and method for preparing mandelic acid compound 江西科苑生物药业有限公司 2023-12-01 CN disclosed
EP-4255879-A1 METHOD FOR PRODUCING FRAMBINONE RHODIA OPERATIONS (FR) 2023-10-11 EP disclosed
EP-3589636-B1 PROCESSES FOR PREPARING ACC INHIBITORS AND SOLID FORMS THEREOF GILEAD SCIENCES INC (US) 2023-09-13 EP disclosed
JP-H05201917-A PRODUCTION OF 2-HYDROXY MANDELIC ACID IMPERIAL CHEM IND PLC <ICI> 1993-08-10 JP disclosed
EP-0536960-A2 Preparation of 2-hydroxymandelic acids and 2-hydroxybenzaldehydes ZENECA LIMITED (GB) 1993-04-14 EP disclosed
EP-0536960-A2 Preparation of 2-hydroxymandelic acids and 2-hydroxybenzaldehydes ZENECA LIMITED (GB) 1993-04-14 EP disclosed
EP-0536960-A2 Preparation of 2-hydroxymandelic acids and 2-hydroxybenzaldehydes ZENECA LIMITED (GB) 1993-04-14 EP disclosed
US-4978784-A Process for industrial manufacture of sodium parahydroxymandelate SOCIETE FRANCAISE HOECHST (FR) 1990-12-18 US disclosed
US-4385006-A Process for preparing aromatic nitriles 501 SOCIETE FRANCAISE HOECHST (FR) 1983-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230416182-A1 PROCESS FOR PREPARING FRAMBIONE GRHPR, FDPS, FPGS LMNA 652/4885MAPK1 3956/4885GABRA1 3770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.